Related Experiment Video
Updated: Jun 17, 2025

Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
Published on: February 10, 2014
Chlorination of epithelial tight junction proteins by neutrophil myeloperoxidase promotes barrier dysfunction and
Ian M Cartwright1,2,3, Liheng Zhou1,2, Samuel D Koch1,2
1Mucosal Inflammation Program and.
Abstract:
Neutrophils (polymorphonuclear leukocytes, PMNs) comprise a major component of the immune cell infiltrate during acute mucosal inflammation and have an important role in molding the inflammatory tissue environment. While PMNs are essential to clearance of invading microbes, the major PMN antimicrobial enzyme myeloperoxidase (MPO) can also promote bystander tissue damage. We hypothesized that blocking MPO would attenuate acute colitis and prevent the development of chronic colitis by limiting bystander tissue damage. Using the acute and chronic dextran sodium sulfate model of murine colitis, we demonstrated that MPO-deficient mice experienced less inflammation and more rapidly resolved colitis relative to wild-type controls. Mechanistic studies demonstrated that activated MPO disrupted intestinal epithelial barrier function through the dysregulation of the epithelial tight junction proteins. Our findings revealed that activated MPO chlorinates tyrosine within several tight junction proteins, thereby promoting tight junction mislocalization and dysfunction. These observations in cell models and in murine colitis were validated in human intestinal biopsies from individuals with ulcerative colitis and revealed a strong correlation between disease severity (Mayo score) and tissue chlorinated tyrosine levels. In summary, these findings implicate MPO as a viable therapeutic target to limit bystander tissue damage and preserve mucosal barrier function during inflammation.
Insights
Blocking myeloperoxidase (MPO) in neutrophils reduces colitis severity and preserves intestinal barrier function. MPO deficiency limits tissue damage, offering a potential therapeutic target for inflammatory bowel diseases.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Neutrophils, including polymorphonuclear leukocytes (PMNs), are key immune cells in mucosal inflammation.
- The neutrophil enzyme myeloperoxidase (MPO) aids microbial clearance but can cause bystander tissue damage.
Purpose of the Study:
- To investigate the role of MPO in acute and chronic colitis.
- To determine if blocking MPO can attenuate colitis and preserve intestinal barrier function.
Main Methods:
- Utilized dextran sodium sulfate (DSS) model for acute and chronic murine colitis.
- Compared MPO-deficient mice with wild-type controls.
- Analyzed intestinal epithelial barrier function and tight junction protein regulation.
- Validated findings in human ulcerative colitis biopsies.
Main Results:
- MPO-deficient mice showed reduced inflammation and faster colitis resolution.
- Activated MPO disrupted intestinal epithelial barrier function by dysregulating tight junction proteins.
- MPO chlorinates tyrosine residues in tight junction proteins, causing mislocalization and dysfunction.
- Human ulcerative colitis biopsies correlated disease severity with elevated chlorinated tyrosine levels.
Conclusions:
- MPO contributes to bystander tissue damage and barrier dysfunction in colitis.
- Targeting MPO may be a viable therapeutic strategy for inflammatory bowel diseases.
- Preserving mucosal barrier function is crucial for managing intestinal inflammation.
Related Concept Videos
Tight Junctions
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Adherens Junctions
Adherens Junctions are Dynamic
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

